Company Search:
Advanced Search
Sponsored Links
Galapagos NV - ADR Company Snapshot
Galapagos NV operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Galapagos NV with three other companies in this sector in the United States: Exelixis, Inc. (2016 sales of $191.45 million ), Natera Inc ($217.07 million of which 100% was Commercial Physical Research), and Retrophin Inc ($133.59 million of which 100% was Biotechnology).

Sales Analysis. Sales increased substantially in 2016: Galapagos NV reported sales of $167.34 million for the year ending December of 2016. This represents an increase of 150.4% versus 2015, when the company's sales were $66.82 million. Sales of R&d saw an increase of 121.7% in 2016, from $60.56 million to $134.23 million. Not all segments of Galapagos NV experienced an increase in sales in 2016: sales of Fee-For-Services fell 28.9% to $8.72 million.
  Stock Performance Chart for Galapagos NV - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 108.38
(Figures in U.S. Dollars)
1 Week 10.2%   13 Weeks 18.8%  
4 Weeks 6.7%   52 Weeks 56.6%  
Galapagos NV - ADR Key Data:
  Ticker: GLPG Country: United States
  Exchanges: NAS OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 167,338,713
(Year Ending Jan 2017).
Employees: 508
  Currency: U.S. Dollars Market Cap: 5,516,084,420
  Fiscal Yr Ends: December Shares Outstanding: 50,895,778
  Share Type: Action Ordinaries Closely Held Shares: 8,422,356
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.